Pacific Strategic Financial Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Pacific Strategic Financial Tbk trades at Rp575 (market cap 6.59T, 834.1K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Pacific Strategic Financial Tbk is far larger — about 20.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Pacific Strategic Financial Tbk is more actively traded (834.1K versus 41.7K). Which is the better fit depends on your goals.
| APIC | DGNS | |
|---|---|---|
Market Cap | 6.59T | 316.25B |
Volume | 834.1K | 41.7K |
Lot | 8.34K | 417 |
Turnover | 462.05M | 9.66M |
Average Price | 553.95 | 231.65 |
Value | 462.05M | 9.66M |
Indicative Equilibrium Price | 575 | 230 |
Indicative Equilibrium Volume | 788 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
Founded in Jakarta on February 22nd 1989 as PT. Citramas Securindo. Name changed to be PT. Arta Pacific Securities on July 4th 2000. Conduct as broker dealer and underwriter in capital market.
Read more on APIC →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →